Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HT, Melphalan, and Fludarabine Conditioning for Stem Cell Transplant
NCT00544466Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Jul 2006
- Primary completion
- Aug 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, melphalan in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by City of Hope. Started Jul 2006; status: active, not recruiting.
02
Drugs
fludarabinemelphalan
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00544466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544466.